In today’s session HCP, Inc. (HCP) registered an unusually high (3,299) contracts volume of call trades. Someone, most probably a professional was a very active buyer of the January, 2017 call, expecting serious HCP increase. With 3,299 contracts traded and 4904 open interest for the Jan, 17 contract, it seems this is a quite bullish bet. The option with symbol: HCP170120C00030000 closed last at: $0.95 or 5.6% up. About 885,416 shares traded hands. HCP, Inc. (NYSE:HCP) has declined 4.38% since April 28, 2016 and is downtrending. It has underperformed by 10.31% the S&P500.
Analysts await HCP, Inc. (NYSE:HCP) to report earnings on February, 14. They expect $0.65 earnings per share, down 18.75% or $0.15 from last year’s $0.8 per share. HCP’s profit will be $303.54M for 11.24 P/E if the $0.65 EPS becomes a reality. After $0.72 actual earnings per share reported by HCP, Inc. for the previous quarter, Wall Street now forecasts -9.72% negative EPS growth.
HCP, Inc. (NYSE:HCP) Ratings Coverage
Out of 15 analysts covering HCP (NYSE:HCP), 1 rate it a “Buy”, 3 “Sell”, while 11 “Hold”. This means 7% are positive. $41 is the highest target while $30 is the lowest. The $33.83 average target is 15.74% above today’s ($29.23) stock price. HCP has been the topic of 28 analyst reports since September 8, 2015 according to StockzIntelligence Inc. Goldman Sachs downgraded the shares of HCP in a report on Monday, September 21 to “Sell” rating. The stock of HCP, Inc. (NYSE:HCP) earned “Buy” rating by Mizuho on Monday, November 21. UBS maintained the shares of HCP in a report on Tuesday, August 23 with “Neutral” rating. The stock of HCP, Inc. (NYSE:HCP) has “Neutral” rating given on Tuesday, March 15 by JP Morgan. Goldman Sachs upgraded the shares of HCP in a report on Friday, July 8 to “Neutral” rating. The rating was upgraded by Jefferies on Tuesday, May 10 to “Hold”. The company was maintained on Wednesday, August 24 by Citigroup. The stock of HCP, Inc. (NYSE:HCP) has “Neutral” rating given on Wednesday, November 2 by Mizuho. Barclays Capital maintained it with “Underweight” rating and $33 target price in Thursday, March 10 report. The firm has “Underweight” rating given on Wednesday, January 6 by Barclays Capital.
According to Zacks Investment Research, “Health Care Property Investors, Inc. is a real estate investment trust. The company invests in health care related real estate located throughout the United States, including long-term care facilities, congregate care and assisted living facilities, acute care and rehabilitation hospitals, medical office buildings, physician group practice clinics and psychiatric facilities.”
Insitutional Activity: The institutional sentiment increased to 0.96 in Q2 2016. Its up 0.04, from 0.92 in 2016Q1. The ratio improved, as 55 funds sold all HCP, Inc. shares owned while 208 reduced positions. 65 funds bought stakes while 177 increased positions. They now own 416.03 million shares or 2.10% less from 424.94 million shares in 2016Q1.
Blue Fincl Cap last reported 0.26% of its portfolio in the stock. Real Estate Mngmt Limited Liability Corporation holds 0.65% or 106,200 shares in its portfolio. Capital Advisors Ok reported 7,214 shares or 0% of all its holdings. Moreover, First Citizens National Bank & Tru Commerce has 0.1% invested in HCP, Inc. (NYSE:HCP) for 31,275 shares. Commonwealth Bank Of Australia reported 46,927 shares or 0.02% of all its holdings. Westpac holds 79,355 shares or 0% of its portfolio. Cohen And Steers accumulated 3.72% or 40.39M shares. Public Employees Retirement Association Of Colorado has invested 0.03% of its portfolio in HCP, Inc. (NYSE:HCP). Verition Fund Mgmt Ltd Llc has 0.05% invested in the company for 10,113 shares. Teacher Retirement Of Texas last reported 33,321 shares in the company. Fiduciary Finance Service Of The Southwest Tx has 142,334 shares for 1.62% of their US portfolio. Envestnet Asset Mngmt Inc has 0.02% invested in the company for 139,640 shares. Keybank Association Oh holds 0.01% of its portfolio in HCP, Inc. (NYSE:HCP) for 46,370 shares. Meeder Asset Mgmt has invested 0% of its portfolio in HCP, Inc. (NYSE:HCP). Toronto Dominion National Bank has 2,559 shares for 0% of their US portfolio.
Insider Transactions: Since August 23, 2016, the stock had 0 insider buys, and 4 selling transactions for $868,491 net activity. Bergschneider Jonathan M. sold $304,387 worth of stock or 7,651 shares. Kirby Thomas D sold $120,725 worth of HCP, Inc. (NYSE:HCP) on Wednesday, September 7. $355,177 worth of HCP, Inc. (NYSE:HCP) shares were sold by Young Kendall K. 2,250 shares were sold by Kowalske Darren A, worth $88,202 on Wednesday, August 31.
HCP, Inc. is a self-administered real estate investment trust (REIT). The company has a market cap of $13.65 billion. The Firm invests in real estate serving the healthcare industry in the United States. It currently has negative earnings. The Company’s portfolio consists of investments in various healthcare divisions: senior housing, post-acute/skilled nursing, life science, medical office and hospital.
HCP Company Profile
HCP, Inc. (HCP), incorporated on March 21, 1985, is a self-administered real estate investment trust (REIT). The Firm invests in real estate serving the healthcare industry in the United States. The Company’s portfolio consists of investments in various healthcare divisions: senior housing, post-acute/skilled nursing, life science, medical office and hospital. The Company’s portfolio includes owned portfolio, unconsolidated joint ventures, and developments and redevelopments. The Firm has interests in unconsolidated joint ventures representing approximately 30 properties primarily in its senior housing, life science and medical office divisions.
Another recent and important HCP, Inc. (NYSE:HCP) news was published by Fool.com which published an article titled: “HCP, Inc. Earnings: An Eventful Quarter” on November 02, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.